Elevance Health Reduces Medicare Footprint, Exits Standalone Part D Plans for Profitability

Elevance Health Inc. (NYSE:ELV) is one of the best inexpensive stocks to buy according to hedge funds. On September 4, Elevance’s CFO, Mark Kaye, announced at the Wells Fargo Healthcare Conference in Boston that the company is reducing its Medicare footprint. The decision is being made to improve the business’s profitability, especially in its Medicare Advantage/MA and standalone Medicare Part D prescription drug plans. Kaye stated that these moves are intended to help Elevance achieve a firmer financial ...